VR Logo

Piramal Enterprises Ltd.


Healthcare | Drugs & Pharma

we think vacations are for wimps

43 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: Manufacture of pharmaceuticals, medicinal chemical and botanical products

Incorporated: 1947

Chairman: Ajay Piramal

Managing Director: --

Group: Piramal Ajay

Listing: NSE: PEL, BSE: 500302

Headquarters: Mumbai, Maharashtra

Website: www.piramal.com

Key Facts

Market cap: R 38,817.40 Cr

Revenue (TTM): R 12,748.79 Cr

Earnings (TTM): R -206.59 Cr

Cash: R 7,721.51 Cr

Total Debt: R 42,054.54 Cr

Promoters' ownership: 46.06%

Liquidity: High

52 Week range: R 802.30 - 2,008.20

Face value: R2.00

Shares outstanding: 22,55,38,290

10 Years Aggregate:

  • CFO: -47,677.91 Cr
  • EBITDA: 24,234.92 Cr
  • Net Profit: 22,283.47 Cr

Stock Performance

Time Period Piramal Enterprises S&P BSE Healthcare S&P BSE Mid Cap
YTD20.4610.8713.88
1 month-1.3311.430.73
3 months11.6310.245.25
1 Year88.9658.9979.36
3 Years-10.8620.157.24
5 Years8.209.1713.33
10 Years14.4714.8411.62
As on 05-May-2021
Year Piramal Enterprises S&P BSE Mid Cap S&P BSE Healthcare
2020-7.0319.8761.45
2019-34.84-3.05-3.55
2018-16.36-13.31-5.89
201776.4648.130.49
201660.887.97-12.88
201520.607.4315.06
201451.5754.6947.43